I have a pretty good track record with NPSP and have been preaching this story for 4+ years now. Add to the revenue picture the fact it is a target for shorts, has analysts circling around a mid $40's price and that it is heavily owned by institutions and it should be all the evidence you need to buy and hold. This is like somebody giving you money if you are simply willing to wait for 6-12 months. We will double by year-end to early 2015. Will be bumpy between but that is the price you pay for a big win. Do not miss this one.
Sentiment: Strong Buy
Just got into this stock again after a big lost in 2005-ish. Thinking about selling some May or June covered calls around $30 on Monday. I'm hoping there will be a run-up this fall as the FDA date of approval approaches. What's your thought?
Maybe so, but what will it trade at in Nov 2014? Do you think it is a take over candidate for Big Pharma? Thank you for your input.
Seems like the sales of Gattex and Revestive have been going great and from what I've read are projected to vastly increase in the coming years. Not sure if 1 flat quarter could derail that progress.
If NPSP can increase the scripts number up for Gattex then it will be in really good shape for the 1Q.
u are correct; i don't think the #'s r picking up as hoped...